Abstract
Proteins fold on a time scale incompatible with a mechanism of random search in conformational space thus indicating that somehow they are guided to the native state through a funneled energetic landscape. At the same time the heterogeneous kinetics suggests the existence of several different folding routes. Here we propose a scenario for the folding mechanism of the monomer of HIV-1 protease in which multiple pathways and milestone events coexist. A variety of computational approaches supports this picture. These include very long all-atom molecular dynamics simulations in explicit solvent, an analysis of the network of clusters found in multiple high-temperature unfolding simulations and a complete characterization of free-energy surfaces carried out using a structure-based potential at atomistic resolution and a combination of metadynamics and parallel tempering. Our results confirm that the monomer in solution is stable toward unfolding and show that at least two unfolding pathways exist. In our scenario, the formation of a hydrophobic core is a milestone in the folding process which must occur along all the routes that lead this protein towards its native state. Furthermore, the ensemble of folding pathways proposed here substantiates a rational drug design strategy based on inhibiting the folding of HIV-1 protease.
Introduction
The HIV-1 protease (HIV-1-PR) is a critical enzyme that the virus uses to mature and become infectious. In its active form, it is a homodimer—two identical protein chains joined together. However, before they can dock, each individual chain (the monomer) must fold into the correct 3D shape. While much is known about the final dimer, the folding transition of the monomer has remained largely a "black box." Understanding this process is vital because the virus frequently mutates to escape traditional drugs that target the enzyme's active site. If the folding process can be mapped, it may be possible to design drugs that disrupt the folding process itself—a strategy that may be more difficult for the virus to circumvent through mutation.
Methods
The researchers employed a sophisticated three-pronged computational approach to capture events that occur on timescales often too fast or complex for standard simulations:
- All-Atom Molecular Dynamics (MD): A 512 ns simulation was performed in explicit solvent to observe the stability and natural fluctuations of the folded monomer.
- High-Temperature Unfolding: To observe the process in reverse, 30 independent simulations were conducted at 700K. By "unraveling" the protein multiple times, the team used k-means clustering and network analysis to map the different structural states visited by the protein.
- Enhanced Sampling (PTMetaD): Parallel Tempering Metadynamics was combined with a structure-based potential. This allowed for the calculation of the Free-Energy Surface (FES)—a topographical map of the energy landscape—to identify the most probable folding routes and barriers.
The study utilized the high-resolution crystal structure of the HIV-1 protease dimer (PDB code: 1BVG). Simulations used the AMBER99SB force field and the TIP3P water model. Additionally, a dataset of 28,417 viral isolates from patients was used to correlate findings with real-world evolutionary conservation of specific protein residues.
Results
Monomer Stability and Pathway Heterogeneity
The simulations confirmed that the HIV-1-PR monomer is stable in solution on its own, addressing earlier suggestions of inherent instability. The folding process was found to be heterogeneous, with at least two distinct unfolding routes identified. In the dominant path, the $\beta 1$ hairpin is the last to unfold; in the alternative path, it unfolds much earlier.
The Hydrophobic Core as a Mandatory Milestone
Despite the multiple pathways, all routes are "funneled" through a mandatory milestone: the formation of a specific hydrophobic core (the folding nucleus). This core, involving fragments near the center of the sequence (residues 24–34 and 83–92), is the first to form during folding and the last to disappear during unfolding. Free-energy calculations revealed a characteristic L-shaped energy landscape for this core, implying that hydrophobic collapse is a sharp, decisive event that must occur before the rest of the protein's secondary structure can lock into place.
Structural Independence and Conservation
The $\beta 2$ region, which forms the "flaps" of the active enzyme, was found to fold almost entirely independently of the rest of the protein. This high flexibility allows the enzyme to open and close during its catalytic cycle. Furthermore, the residues identified as part of the "milestone" core are the most highly conserved in clinical samples. The virus rarely mutates these areas, as doing so would likely compromise the protein's ability to fold entirely.
Discussion
This research provides a detailed map of the HIV-1-PR monomer folding landscape, highlighting a conserved hydrophobic core as a critical milestone. This discovery substantiates a rational drug design strategy based on inhibiting the folding process, specifically targeting the p-$S_8$ peptide fragment.
While the study offers deep insights into the single chain, future work is needed to simulate the "docking" process where two folded monomers form the active dimer. Additionally, the folding inhibitor strategy requires further experimental validation to determine its viability as a clinical therapy.
References
Bonomi M, Barducci A, Gervasio FL, Parrinello M (2010) Multiple Routes and Milestones in the Folding of HIV–1 Protease Monomer. PLoS ONE 5(10): e13208.
Summary updated